Ticker
CNTBCompany Name
CONNECT BIOPHARMA HOLDINGS LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 131.5M | $ 288K | $ 148K | $ 0 | 0% |
3/31/2025 | $ 40.39M | $ 0 | $ 0 | $ 0 | 0% |
12/31/2024 | $ 30.44M | $ 227K | $ 0 | $ 0 | -0.75% |
6/30/2024 | $ 65.62M | $ 125.04K | $ -293.33K | $ 0 | 0% |
12/31/2023 | $ 95.33M | $ 44K | $ -290K | $ 0 | 0.26% |
6/30/2023 | $ 41.72M | $ 39.05K | $ -279.62K | $ 0 | 0% |
12/31/2022 | $ 62.75M | $ 121.93K | $ -207.56K | $ 0 | 0.14% |
6/30/2022 | $ 80.39M | $ -21.92K | $ -117.14K | $ 0 | 0% |
12/31/2021 | $ 166.33M | $ 195.68M | $ -110.28K | $ 0 | -117.58% |
6/30/2021 | $ 1.35B | $ 0 | $ 0 | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for CONNECT BIOPHARMA HOLDINGS LTD is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ -73.71K ]) / Market Cap [ $ 0 ]
(=) Shareholder Yield [ 0% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.38% |
max | 34.45% |
average | 0.59% |
median | 1.08% |
std | 11.11% |